Results per Page:
Dysregulated purine metabolism produces profound neurodevelopmental defects
From the Kollman and Wills Labs, University of Washington Biochemistry Department
MGRN1 and ATRN cooperate to regulate melanocortin signaling
From the Kong Lab, University of Washington Biochemistry Department
Engineering B cells to improve HIV treatments
From the Kiem lab, Translational Sciences and Therapeutics Division
Bone marrow stroma (synde)can make a big difference to hematopoietic stem cells
From the Termini Lab, Translational Sciences and Therapeutics Division
New drug regimen prevents both chronic and acute graft-versus-host disease
From Dr. Masumi Ueda Oshima and colleagues, Clinical Research Division
New clinical trials to target HER2 positive solid cancers
From Dr. Sara Hurvitz, Clinical Research Division, and colleagues
Data-driven enrollment for COVID-19 vaccine clinical trials
From the HIV Vaccine Trials Network/COVID-19 Prevention Network
New cell segmentation methods for better spatial transcriptomics
From the Newell Lab, Vaccine and Infectious Disease Division
New models for patient-derived head and neck cancers
From the Beronja Lab and Dr. Brittany Barber
En la búsqueda del fundamento genético de la dislexia
De las doctoras Wendy Raskind, Ellen Wijsman y sus colegas de la Universidad de Washington.
Picking brains with new single-cell techniques
From the Singhvi and Setty Labs, Basic Sciences Division
ReLiC: A genetic screening method to study RNA regulation
From the Subramaniam Lab, Basic Sciences Division
Mitochondrial minerals and metabolic manipulation
From the Sancak Lab, University of Washington
Search for the genetic basis of dyslexia
From Drs. Wendy Raskind, Ellen Wijsman, and colleagues, University of Washington.
Conditionally activated immunotherapies alleviate cancer treatment toxicity
From the Fong Lab, Translational Sciences and Therapeutics
Improving delivery of monoclonal antibody therapies in resource-limited settings
From researchers in the Translational Sciences and Therapeutics and Vaccines and Infectious Disease Divisions
A tale of two T-cells: comparing liso-cel and axi-cel for treatment of refractory large B-cell lymphoma
From the Gauthier group, Clinical Research Division
Pediatric cancer survivors have a higher risk of chronic health conditions
From Dr. Wendy Liesenring, Clinical Research Division
AMP-ed on HIV prevention
From the McElrath Lab, Vaccine and Infectious Disease Division
Natural born killers: harnessing innate immunity to fight severe infections
From the Joshua Hill lab, Vaccine and Infectious Disease Division